Annual ROE
-41.00%
+7.13%+14.81%
December 31, 2023
Summary
- As of February 7, 2025, PLRX annual return on equity is -41.00%, with the most recent change of +7.13% (+14.81%) on December 31, 2023.
- During the last 3 years, PLRX annual ROE has fallen by -11.61% (-39.50%).
- PLRX annual ROE is now -101.19% below its all-time high of 3432.65%, reached on December 31, 2018.
Performance
PLRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-48.91%
-7.86%-19.15%
September 30, 2024
Summary
- As of February 7, 2025, PLRX quarterly return on equity is -48.91%, with the most recent change of -7.86% (-19.15%) on September 30, 2024.
- Over the past year, PLRX quarterly ROE has dropped by -7.86% (-19.15%).
- PLRX quarterly ROE is now -240.18% below its all-time high of 34.89%, reached on March 31, 2020.
Performance
PLRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PLRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.8% | -19.1% |
| 3 y3 years | -39.5% | -19.1% |
| 5 y5 years | -101.2% | -1313.6% |
PLRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.6% | +14.8% | -57.0% | +11.8% |
| 5 y | 5-year | -128.3% | +14.8% | -240.2% | +11.8% |
| alltime | all time | -101.2% | +14.8% | -240.2% | +58.3% |
Pliant Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -48.91%(+19.1%) |
| Jun 2024 | - | -41.05%(+17.0%) |
| Mar 2024 | - | -35.08%(+12.6%) |
| Dec 2023 | -41.00%(-14.8%) | -31.15%(-4.2%) |
| Sep 2023 | - | -32.50%(-14.8%) |
| Jun 2023 | - | -38.14%(-11.9%) |
| Mar 2023 | - | -43.28%(-17.8%) |
| Dec 2022 | -48.13%(+19.3%) | -52.66%(+0.7%) |
| Sep 2022 | - | -52.31%(-5.6%) |
| Jun 2022 | - | -55.44%(+19.1%) |
| Mar 2022 | - | -46.53%(+15.8%) |
| Dec 2021 | -40.35% | -40.17%(+14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -34.97%(+21.1%) |
| Jun 2021 | - | -28.87%(+2.3%) |
| Mar 2021 | - | -28.21%(+45.6%) |
| Dec 2020 | -29.39%(-120.3%) | -19.37%(-294.5%) |
| Sep 2020 | - | 9.96%(-29.3%) |
| Jun 2020 | - | 14.08%(-59.6%) |
| Mar 2020 | - | 34.89%(-1108.4%) |
| Dec 2019 | 145.06%(-95.8%) | -3.46%(-97.0%) |
| Sep 2019 | - | -117.17%(+44.9%) |
| Jun 2019 | - | -80.88%(+108.7%) |
| Mar 2019 | - | -38.75% |
| Dec 2018 | 3432.65% | - |
FAQ
- What is Pliant Therapeutics annual return on equity?
- What is the all time high annual ROE for Pliant Therapeutics?
- What is Pliant Therapeutics annual ROE year-on-year change?
- What is Pliant Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly ROE year-on-year change?
What is Pliant Therapeutics annual return on equity?
The current annual ROE of PLRX is -41.00%
What is the all time high annual ROE for Pliant Therapeutics?
Pliant Therapeutics all-time high annual return on equity is 3432.65%
What is Pliant Therapeutics annual ROE year-on-year change?
Over the past year, PLRX annual return on equity has changed by +7.13% (+14.81%)
What is Pliant Therapeutics quarterly return on equity?
The current quarterly ROE of PLRX is -48.91%
What is the all time high quarterly ROE for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly return on equity is 34.89%
What is Pliant Therapeutics quarterly ROE year-on-year change?
Over the past year, PLRX quarterly return on equity has changed by -7.86% (-19.15%)